OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes

Emilio Sacco, Marco Racioppi, Pierfrancesco Bassi, Daniele Tienforti, Riccardo Bientinesi, Alessandro D'Addessi, Francesco Pinto, Angelo Totaro, Matteo Vittori, Daniele D'Agostino

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To determine efficacy and safety of OnabotulinumtoxinA (BoNT-A) injection therapy in medically refractory patients with lower urinary tract symptoms (LUTS) due to primary bladder-neck dysfunction (PBND).
Original languageEnglish
Pages (from-to)142-146
Number of pages5
JournalNeurourology and Urodynamics
Volume33
DOIs
Publication statusPublished - 2014

Keywords

  • lower urinary tract symptoms
  • onabotulinumtoxina
  • primary bladder-neck dysfunction
  • urinary bladder-neck obstruction

Fingerprint

Dive into the research topics of 'OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes'. Together they form a unique fingerprint.

Cite this